Show HN: AI agents can now safely write to your CRMs
Archron launches an execution governance layer that lets AI agents write to Salesforce and HubSpot with immutable audit logs, offering a 3-month free trial.
Archron, a new tool for AI execution governance, launched publicly on August 20, 2026 via a Show HN post by founder rjimena. The product lets AI agents write to CRM platforms — starting with Salesforce and HubSpot — while keeping immutable audit logs of every action taken.
The core proposition, per the Show HN post, is governance: as AI agents become more capable of taking autonomous actions inside business software, Archron positions itself as a control layer that ensures those writes are traceable and auditable. The founder describes it as "execution governance for AI in business." To drive adoption, the company is offering 3 months free for businesses that want to test it in their workflows.
Archron is currently targeting two of the most widely used CRM platforms — Salesforce and HubSpot — with the framing that additional integrations may follow, though no specific roadmap is mentioned in the launch post. A demo video is available on YouTube.
The launch sits at the intersection of two converging pressures on enterprise software teams: the rapid proliferation of AI agents being deployed to automate business workflows, and the compliance and auditability requirements those deployments trigger. CRMs hold sensitive customer data, and uncontrolled agent writes — duplicated records, incorrect field updates, or data deletions — carry real business risk. Archron's pitch is that an immutable log layer addresses that risk without requiring businesses to block agent access entirely.
No funding, team size, or founding date is disclosed in the source material. The product appears to be an early-stage, solo or small-team project; the founder invites direct feedback and contact at rjimena@archron.app, per the Show HN post. The free trial offer suggests the company is in an early customer discovery and validation phase.
No comments yet — start the thread.